Default

Allergy and immunology

Anaesthesia

Basic research

Cardiovascular medicine

Complementary medicine and alternative therapies

Critical care / intensive care

Dentistry / oral medicine

Dermatology

Emergency medicine

Endocrinology

Epidemiology

Ethics

Evidence-based medicine

Gastroenterology

Genetics

Geriatric medicine / aging

Haematology / blood transfusion

Health economics

Health policy

History of medicine

Infectious diseases

Internal medicine

Laboratory medicine

Medical education

Medical informatics

Neurology

Nursing

Nutrition and metabolism

Obstetrics and gynaecology

Occupational and environmental medicine

Oncology

Ophthalmology

Organisation of health care

Otolaryngology / head and neck surgery

Paediatrics

Palliative care

Pathology

Patient-physician relationship

Pharmacology and therapeutics

Primary care, family medicine

Psychiatry and psychotherapy

Psychosomatics

Public health

Quality of care

Radiology

Rehabilitation medicine

Renal medicine

Respiratory medicine

Rheumatology

Sexual medicine

Sports medicine

Statistics and research methods

Surgery

Transplantation

Travel medicine

Urology

Ops! No article found. Reset filter

Prevalence of genetic susceptibility for breast and ovarian cancer in a non-cancer related study population: secondary germline findings from a Swiss single centre cohort

Original article
Kraemer D, Azzarello-Burri S, Steindl K, Boonsawat P, Zweier M, Dedes KJ, Joset P, Fink D, Rauch A
Swiss Med Wkly. 2019;149:w20092

Since the advent of high-throughput sequencing technologies, organised germline screening, independent of personal and family cancer history, has been frequently proposed. A critical prerequisite is knowledge of the expected carrier frequencies.

A new era of gene editing for the treatment of human diseases

Review article: Biomedical intelligence
KC M, Steer CJ
Swiss Med Wkly. 2019;149:w20021

Significant advances in the field of gene editing have not only provided new tools for genetic surgery, but have also heralded a new era of medicine, with possibilities never imagined even half a century ago.

Genetics and epigenetics of inflammatory bowel disease

Review article: Biomedical intelligence
Wawrzyniak M, Scharl M
Swiss Med Wkly. 2018;148:w14671

Current knowledge about genetic and epigenetic involvement in the pathogenesis of inflammatory bowel disease is poor. In addition to genetic alterations, the intestinal microbiota and environmental factors also play a critical role.

Recommendations for genetic testing and counselling after sudden cardiac death: practical aspects for Swiss practice

Review article: Biomedical intelligence
Medeiros Domingo A, Bolliger S, Gräni C, Rieubland C, Hersch D, Asatryan B, Schyma C, Saguner A, Wyler D, Bhuiyan Z, Fellman F, Osculati AM, Ringger R, Fokstuen S, Sabatasso S, Wilhelm M, Michaud K, Swiss Working Group on Sudden Cardiac Death
Swiss Med Wkly. 2018;148:w14638

Genetic testing can reveal substrates for cardiomyopathies and channelopathies, as well as aortic diseases and premature atherosclerosis, which may explain some sudden cardiac deaths.

Diffuse large B-cell lymphoma chemotherapy reveals a combined immunodeficiency syndrome in cartilage hair hypoplasia

Original article
Nguyen A, Martin Silva N, de Boysson H, Damaj G, Aouba A
Swiss Med Wkly. 2018;148:w14606

Cartilage hair hypoplasia is a rare autosomal recessive ribosomopathy related to a mutation in the ribonuclease mitochondrial RNA processing (RMRP) gene, which encodes the mitochondrial portion of the RNA processing endonuclease.

Precision medicine for monogenic diabetes: from a survey to the development of a next-generation diagnostic panel

Original article
Kherra S, Blouin JL, Santoni F, Schwitzgebel V
Swiss Med Wkly. 2017;147:w14535

Monogenic diabetes most frequently presents as maturity onset diabetes of the young (MODY), an autosomal dominant disorder leading to beta cell dysfunction.

Strong, generous support for medical research emerges from a large cohort of Swiss patients

Viewpoint
Aguzzi A
Swiss Med Wkly. 2017;147:w14537

The message conveyed by the study of Bochud and colleagues is uplifting. Patients regard medical scientists as sufficiently dependable to be trusted with their most sensitive asset – their genetic and biochemical makeup.

Ascending aortic remodelling in Fabry disease after long-term enzyme replacement therapy

Original article
Monney P, Qanadli SD, Hajdu S, Tran C, Schwitter J, Dormond O, Barbey F
Swiss Med Wkly. 2017;147:w14517

Fabry disease is an X-linked disorder caused by deficiency of the lysosomal α-galactosidase A. This defect leads to progressive accumulation of glycosphingolipids in many tissues, including arterial endothelial and smooth muscle cells.

High participation rate among 25 721 patients with broad age range in a hospital-based research project involving whole-genome sequencing – the Lausanne Institutional Biobank

Original article
Bochud M, Currat C, Chapatte L, Roth C, Mooser V
Swiss Med Wkly. 2017;147:w14528

Surveys indicate a relatively high interest in genetics from the general population and from patients. Also, patients engaged within genetic research are generally interested in being informed about clinically actionable incidental findings.

Genetic determinants of the epigenome in development and cancer

Review article: Biomedical intelligence
Bird A
Swiss Med Wkly. 2017;147:w14523

An increasing number of disease states involve misregulation of readers, writers or erasers of epigenetic information, emphasising their key role as modulators of gene activity.

Verpassen Sie keinen Artikel!

close